Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Guyton

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
Diabetes|October 1, 1978
A model of glucose-insulin homeostasis in man that incorporates the heterogeneous fast pool theory of pancreatic insulin releaseJ R Guyton, R O Foster, J S Soeldner, et al.
Journal of Clinical Lipidology|September 1, 2016
Statin intolerance in a referral lipid clinicWanda C Lakey, Nicole G Greyshock, Carly E Kelley, et al.
The American Journal of Cardiology|January 23, 1999
Efficacy and safety of an extended-release niacin (Niaspan): a long-term studyD M Capuzzi, J R Guyton, J M Morgan, et al.
Journal of Clinical Lipidology|December 16, 2014
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trialPatrick M Moriarty, Terry A Jacobson, Eric Bruckert, et al.
Journal of Clinical Lipidology|February 5, 2011
Optimal management of lipids in diabetes and metabolic syndromeW Virgil Brown, Luther Clark, James M Falko, et al.
Chemical Research in Toxicology|June 1, 1996
Identification and quantification of regioisomeric cholesteryl linoleate hydroperoxides in oxidized human low density lipoprotein and high density lipoproteinJ A Kenar, C M Havrilla, N A Porter, et al.
The American Journal of Cardiology|January 15, 1990
Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery diseaseW S Weintraub, E L Jones, S B King, et al.
Mayo Clinic Proceedings|December 15, 2006
Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL studyRonald B Goldberg, John R Guyton, Theodore Mazzone, et al.
Plos Genetics|May 6, 2010
Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart StudySunil Suchindran, David Rivedal, John R Guyton, et al.
Diabetes, Obesity & Metabolism|February 22, 2011
Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trialsL A Leiter, D J Betteridge, M Farnier, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Diabetes|October 1, 1978
A model of glucose-insulin homeostasis in man that incorporates the heterogeneous fast pool theory of pancreatic insulin releaseJ R Guyton, R O Foster, J S Soeldner, et al.
Journal of Clinical Lipidology|September 1, 2016
Statin intolerance in a referral lipid clinicWanda C Lakey, Nicole G Greyshock, Carly E Kelley, et al.
The American Journal of Cardiology|January 23, 1999
Efficacy and safety of an extended-release niacin (Niaspan): a long-term studyD M Capuzzi, J R Guyton, J M Morgan, et al.
Journal of Clinical Lipidology|December 16, 2014
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trialPatrick M Moriarty, Terry A Jacobson, Eric Bruckert, et al.
Journal of Clinical Lipidology|February 5, 2011
Optimal management of lipids in diabetes and metabolic syndromeW Virgil Brown, Luther Clark, James M Falko, et al.
Chemical Research in Toxicology|June 1, 1996
Identification and quantification of regioisomeric cholesteryl linoleate hydroperoxides in oxidized human low density lipoprotein and high density lipoproteinJ A Kenar, C M Havrilla, N A Porter, et al.
The American Journal of Cardiology|January 15, 1990
Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery diseaseW S Weintraub, E L Jones, S B King, et al.
Mayo Clinic Proceedings|December 15, 2006
Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL studyRonald B Goldberg, John R Guyton, Theodore Mazzone, et al.
Plos Genetics|May 6, 2010
Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart StudySunil Suchindran, David Rivedal, John R Guyton, et al.
Diabetes, Obesity & Metabolism|February 22, 2011
Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trialsL A Leiter, D J Betteridge, M Farnier, et al.
Pageof 17